Page 15 - Lobe Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Plans to Develop and Launch A Global Registry For The Identification and Long Term Management of Current and Former Boxers With mTBI and PTSDInsights Derived From This Project Will Help Guide The Development Of Guidelines and Treatment Goals For The WBA FamilyLobe Sciences Ltd. is pleased to announce that the Company plans to develop and launch a global registry for the identification and long term management of ...

Lobe Sciences Ltd.: Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe" or the " Company") is pleased to announce it has entered into a production and supply agreement (the "Agreement") on May 14, 2021 with HAVN Life Sciences Inc. (CSE: HAVN) (OTC Pink: HAVLF) (FSE: 5NP) ("HAVN"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products. Pursuant to t...

Havn Life Sciences Inc.: HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "HAVN Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply agreement (the "Agreement") with Lobe Sciences Ltd. (LOBE) (GTSIF), an innovative biotech company committed to investigating and developing treatments using psychedelic and non-...

HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings ACCESSWIRE Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility (the 'Company' or 'HAVN Life'), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply agreement (the 'Agreement') with Lobe Sciences Ltd. (LOBE) (GTSIF), an innovative biotech company committed to investigating and developing treatments using psychedelic and non-traditional medicines for bett...

Lobe Sciences Ltd.: Lobe Sciences to Present at the Benzinga Global Small Cap Conference Lobe" or the " Company") is pleased to announce that it will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. Philip Young, CEO and Director will be presenting on Thursday May 13 th at 12:25 pm ET. Philip Young, CEO and Director of Lobe, stated, "We look forward to discussing the latest developments and opportunities ahead of us as we continue on our mission to improve the health of people globally by improving the human condition." For more information and/or to ...